Inventor · disambiguated record
Michael Howell
Also filed as: HOWELL MICHAEL · HOWELL MICHAEL D · HOWELL MICHAEL DWIGHT · HOWELL MICHAEL W
23 granted patents·20 pending applications·175 citations·filing 2000–2024
94Inventor score
Top patents by PatentIndex Score
43 records- 0195US11304949B2Treatment of hidradenitis suppurativa using JAK inhibitorsINCYTE CORP·Filed 2019·Granted Apr 19, 2022·8 cites·17 claims
- 0294US6252494B1Timed dispenser for programmed fluid consumptionFiled 2000·Granted Jun 26, 2001·90 cites·11 claims
- 0392US9023995B2Anti IL-36R antibodiesBOEHRINGER SOHN INGELHEIM·Filed 2012·Granted May 5, 2015·43 cites·36 claims
- 0491US11372003B2Biomarkers for graft-versus-host diseaseINCYTE CORP·Filed 2019·Granted Jun 28, 2022·4 cites·34 claims
- 0590US11590137B2Ruxolitinib formulation for reduction of itch in atopic dermatitisINCYTE CORP·Filed 2022·Granted Feb 28, 2023·2 cites·27 claims
- 0688US11957661B2JAK1 pathway inhibitors for the treatment of vitiligoINCYTE CORP·Filed 2021·Granted Apr 16, 2024·2 cites·13 claims
- 0787US11510923B2Ruxolitinib formulation for reduction of itch in atopic dermatitisINCYTE CORP·Filed 2020·Granted Nov 29, 2022·2 cites·18 claims
- 0886US11602536B2Topical treatment of vitiligo by a JAK inhibitorINCYTE CORP·Filed 2020·Granted Mar 14, 2023·2 cites·23 claims
- 0985US10550189B2Anti IL-36R antibodiesBOEHRINGER INGELHEIM INT·Filed 2015·Granted Feb 4, 2020·6 cites·21 claims
- 1084US2024409648A1Anti il-36r antibodiesBOEHRINGER INGELHEIM INT·Filed 2024·Application pending·0 cites
- 1182US11584961B2Biomarkers for inflammatory skin diseaseINCYTE CORP·Filed 2019·Granted Feb 21, 2023·2 cites·36 claims
- 1282US10632267B2Inhaler housingMIRROR 5 LTD·Filed 2016·Granted Apr 28, 2020·9 cites·12 claims
- 1381US12070323B2System and method for generating diagnostic health information using deep learning and sound understandingGOOGLE LLC·Filed 2018·Granted Aug 27, 2024·5 cites·15 claims
- 1479US12280054B2Treatment of hidradenitis suppurativa using JAK inhibitorsINCYTE CORP·Filed 2022·Granted Apr 22, 2025·0 cites·10 claims
- 1577US12396993B2Ruxolitinib formulation for reduction of itch in atopic dermatitisINCYTE CORP·Filed 2022·Granted Aug 26, 2025·0 cites·25 claims
- 1677US12099068B2Biomarkers for graft-versus-host diseaseINCYTE CORP·Filed 2022·Granted Sep 24, 2024·0 cites·32 claims
- 1776US12233067B2Topical treatment of vitiligo by a JAK inhibitorINCYTE CORP·Filed 2022·Granted Feb 25, 2025·0 cites·15 claims
- 1873US11590138B2Topical treatment of vitiligo by a jak inhibitorINCYTE CORP·Filed 2022·Granted Feb 28, 2023·0 cites·21 claims
- 1973US2025201413A1Predicting health-related events using neural networksGOOGLE LLC·Filed 2024·Application pending·0 cites
- 2072US12498382B2Biomarkers for vitiligoINCYTE CORP·Filed 2022·Granted Dec 16, 2025·0 cites·13 claims
- 2170US2020231684A1Anti il-36r antibodiesBOEHRINGER INGELHEIM INT·Filed 2019·Application pending·0 cites
- 2269US2024358680A1Jak1 pathway inhibitors for the treatment of vitiligoINCYTE CORP·Filed 2024·Application pending·0 cites
- 2369US2024366148A1System and Method for Generating Diagnostic Health Information Using Deep Learning and Sound UnderstandingGOOGLE LLC·Filed 2024·Application pending·0 cites
- 2468US2023293431A1Topical treatment of vitiligo by a jak inhibitorINCYTE CORP·Filed 2023·Application pending·0 cites
- 2567US2024347148A1Macro-based diagnoses for anatomic pathologyCEREBRUM HOLDING CORP·Filed 2024·Application pending·0 cites
- 2664US12020784B2Macro-based diagnoses for anatomic pathologyCEREBRUM HOLDING CORP·Filed 2023·Granted Jun 25, 2024·0 cites·20 claims
- 2762US11624751B2Biomarkers for vitiligoINCYTE CORP·Filed 2020·Granted Apr 11, 2023·0 cites·8 claims
- 2861US2023364095A1Topical treatment of vitiligoINCYTE CORP·Filed 2021·Application pending·0 cites
- 2958US2022162682A1Assessment of mutation burden in skinDERMTECH INC·Filed 2021·Application pending·0 cites
- 3058US2024191309A1Gene classifiers and uses thereofDERMTECH INC·Filed 2022·Application pending·0 cites
- 3156US2024417400A1Aryl hydrocarbon receptor (ahr) modulators and therapeutic uses thereofGALILEO BIOSYSTEMS INC·Filed 2022·Application pending·0 cites
- 3254US2024167102A1Predicting therapeutic responseDERMTECH INC·Filed 2022·Application pending·0 cites
- 3353US2024417399A1Aryl hydrocarbon receptor (ahr) modulators and therapeutic uses thereofGALILEO BIOSYSTEMS INC·Filed 2022·Application pending·0 cites
- 3452US2023143893A1Isolation and purification of exosomes for regenerative medicineAVEM HOLDINGS LLC·Filed 2021·Application pending·0 cites
- 3551US12360120B2Biomarkers for graft-versus-host diseaseINCYTE CORP·Filed 2020·Granted Jul 15, 2025·0 cites·41 claims
- 3651US12203942B2Biomarkers for graft-versus-host diseaseINCYTE CORP·Filed 2020·Granted Jan 21, 2025·0 cites·28 claims
- 3750US2022387005A1Sample collection systemDERMTECH INC·Filed 2022·Application pending·0 cites
- 3849US2021030672A1Topical treatment of vitiligo by a jak inhibitorINCYTE CORP·Filed 2020·Application pending·0 cites
- 3948US11972845B2Macro-based diagnoses for anatomic pathologyCEREBRUM CORP·Filed 2018·Granted Apr 30, 2024·0 cites·20 claims
- 4048US2007271680A1Adjustable sock for people with diabetes and injuriesHOWELL HARRY M·Filed 2006·Application pending·0 cites
- 4146US2021148910A1Compositions and methods for treatment of atopic dermatitis and treatment selectionMEDIMMUNE LLC·Filed 2018·Application pending·0 cites
- 4245US2007078031A1Golf yardage guideMANNIES GARY·Filed 2005·Application pending·0 cites
- 4334US2019103171A1Configurable workflow for pathology labsCEREBRUM CORP·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Michael Howell files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →